๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical use of non-a botulinum toxins: Botulinum toxin type C and botulinum toxin type F

โœ Scribed by Roberto Eleopra; Valeria Tugnoli; Rocco Quatrale; Ornella Rossetto; Cesare Montecucco; Dirk Dressler

Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
850 KB
Volume
9
Category
Article
ISSN
1029-8428

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Clostridium botulinum type C toxin
Clostridium botulinum type C toxin
โœ Bunei Syuto; Shuichiro Kubo ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 538 KB
Botulinum toxin antibody type A titres a
Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy
โœ Dirk Dressler; Hans Bigalke ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 145 KB

## Abstract In some patients, therapy with botulinum toxin type A (BTโ€A) becomes ineffective due to formation of antibodies (BTโ€Aโ€AB). The time course of BTโ€Aโ€AB titres after cessation of BTโ€A therapy was quantitatively studied to determine whether and when they might drop. Thirteen patients (eight

Use of botulinum toxin type F injections
Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A
โœ Dr. Paul E. Greene; Stanley Fahn ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 492 KB

## Abstract Fifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after